Journals / Medicine Science / 2018 / Cilt: 7 - Sayı: 3

Analysis of choroidal thickness in dry type of age-related macular degeneration using spectral-domain optical coherence tomography

Pages
552–556
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, it was observed that choroidal thickness can be analysed by spectral-domain optical coherence tomography and choroidal thickness in patients with dry type of age releated macular degeneration is appeared to be thinner than normal age-matched population.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To evaluate and compare the choroidal thickness in old-aged (>45 years) patients with dry type of age releated macular degeneration and age-matched normal population using spectral-domain optical coherence tomography.
📊
Key Findings & Data:The study consists of 2 study and 1 control groups.
💡
Conclusion & Impact:In our study, it was observed that choroidal thickness can be analysed by spectral-domain optical coherence tomography and choroidal thickness in patients with dry type of age releated macular degeneration is appeared to be thinner than normal age-matched population.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

To evaluate and compare the choroidal thickness in old-aged (>45 years) patients with dry type of age releated macular degeneration and age-matched normal population using spectral-domain optical coherence tomography. A cross-sectional study was conducted in a tertiary eye clinic center. The study consists of 2 study and 1 control groups. Fifty-three eyes of 27 patients and 56 eyes of 28 patiens who were firstly diagnosed with dry type of age releated macular degeneration were participated in the study groups and 64 eyes of 32 individuals without any retinal or choroidal disorder were participated in the control group. All 173 eyes underwent a detailed ophthalmologic examination including optical coherence tomography. An experienced observer measured choroidal thickness using spectral-domain optical coherence tomography. No statistically significiant difference was established between the means of age among three groups. The distribution of choroidal thickness measurements demonstrated a normal distribution in all 3 groups. No statistically significant differences were found between the study groups in terms of mean choroidal thickness, but there were significant differences in mean choroidal thickness between the control group and both study groups. In our study, it was observed that choroidal thickness can be analysed by spectral-domain optical coherence tomography and choroidal thickness in patients with dry type of age releated macular degeneration is appeared to be thinner than normal age-matched population.

🔖

Cite This Article

Akpolat, Ç., KARADAŞ, A., KURT, M. M., EVLİYAOĞLU, F., ERDEN, B., ELÇİOĞLU, M. N. (2018). Analysis of choroidal thickness in dry type of age-related macular degeneration using spectral-domain optical coherence tomography. Medicine Science, Cilt: 7 - Sayı: 3, 552–556. https://ajindex.com/articles/277232

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol.1998;116:653-8
  2. Klein R, Peto T, Bird A, et al. The epidemiology of age-related macular degeneration. Am J Ophthalmol. 2004;137:486-95.
  3. Von Ruckmann A, Fitzke FW, Bird AC. Fundus autofluorescence in agerelated macular disease imaged with a laser scanning Ophthalmoscope. Vis Sci.1997;38:478-86.
  4. Tolentino MJ, Brucker AJ, Fosnot J, et al. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization. Retina. 2004;24:660 Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:722732. Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev. 2012;6:CD000253. Cochrane Database Syst Rev. 2017;30:7 Bergers G, Song S, Meyer-Morse N, et al. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003;111:1287-95.
  5. Bradley J, Ju M, Robinson GS. Combination therapy for the treatment of ocular neovascularization. Angiogenesis. 2007;10:141-8.
  6. Chan WM, Lai TY, Tano Y, et al. Photodynamic therapy in macular diseases of asian populations: when East meets West. Jpn J Ophthalmol. 2006;50:1619. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-81.
  7. Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res. 2008;27:45-88.
  8. Sander B, Larsen M, Thrane L, et al. Enhanced optical coherence tomography imaging by multiple scan averaging. Br J Ophthalmol. 2005;89:207-12.
  9. Ferguson RD, Hammer DX, Paunescu LA, et al. Tracking optical coherence tomography. Opt Lett. 2004;29:2139-41
  10. Potsaid B, Gorczynska I, Srinivasan VJ, et al. Ultrahigh speed spectral / Fourier domain OCT ophthalmic imaging at 70,000 to 312,500 axial scans per second. Opt Express. 2008;16:15149-69.
  11. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectraldomainopticalcoherence tomography. Am J Ophthalmol. 2008;146:496-500.
  12. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes.